Isoflurane from Aesica Queenborough

Aesica Development Manufacture API & Finished Dose — a leading pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services.

Producer

Produced in:

United Kingdom

MOQ: -

  • GMP

  • CoA

  • CEP

  • FDA

  • USDMF

Contact supplier

Replies slower than most

Aesica Queenborough Isoflurane API Producer - 26675-46-7

Description:
Aesica Queenborough offers high-quality Isoflurane API, certified for compliance with international standards. Manufactured in United Kingdom.

Product Details

Certifications
GMP, CoA, CEP, FDA, USDMF compliant
Minimum Order Quantity
Produced in
United Kingdom (Europe)
DrugBank ID
DB00753
CAS Number
26675-46-7
Unique Ingredient Identifier
CYS9AKD70P
Raw Material Category
Inhalation anesthetics

Ordering Process

1. Inquiry Submission: Click "Send Inquiry" to connect directly with producer.

2. Requirement Specification: Outline your needs for tailored offers.

3. Quotation: Receive the best quote and terms exclusively through Pharmaoffer.

Additional Products

We offer 3 other Active Pharmaceutical Ingredients and excipients, showcasing our production and distribution capabilities.

Contact Us

Are you looking for Isoflurane API? Contact Aesica Queenborough by using the send inquiry button. We will respond quickly with pricing and terms exclusively through Pharmaoffer.

Please, provide enough information regarding your inquiry. Let us know whether you require Ph.Eur (EP), USP, BP, JP grade, whether you are looking for hydrochloride (HCl), base, or other specific product specifications. Additionally, please inform us if the API is intended for your own production, resale, or research purposes. Contact us to receive a quote, download certificates, and purchase the Isoflurane API

Aesica Queenborough


Aesica Development Manufacture API & Finished Dose — a leading pharmaceutical CDMO serving pharmaceutical companies with active pharmaceutical ingredient (API) and finished dose formulation development and manufacturing services.